相关实验视频

Updated: Jul 19, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

新辅助免疫检查点封锁:促进癌症免疫疗法的机会之窗

Suzanne L Topalian¹, Patrick M Forde², Leisha A Emens³

¹Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

|August 18, 2023

概括

手术前的新辅助免疫检查点阻塞 (ICB) 疗法通过修改T细胞来增强抗瘤免疫力. 这种方法为发现生物标志物和改进癌症治疗策略提供了机会.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症治疗癌症治疗

背景情况:

新辅助疗法是在癌症治疗手术前进行的.
传统的新辅助疗法旨在缩小瘤以进行手术切除.
免疫检查点封锁 (ICB) 是一种快速发展的癌症治疗方法.

研究的目的:

审查癌症新辅助免疫检查点封锁 (ICB) 的进展.
探索新助剂ICB在增强抗瘤免疫力的潜力.
确定ICB反应和耐药性的生物标志物和机制.

主要方法:

对新辅助剂ICB的临床和科学证据的审查.
对T细胞扩张和转录修饰的分析.
探索免疫疗法研究的"机会窗口".

主要成果:

新辅助ICB扩大和修改瘤特异性T细胞克隆.
观察到增强的内和全身抗瘤免疫力.
识别ICB反应和耐药性的潜在生物标志物.

结论:

新辅助剂ICB代表了癌症治疗的重大进展.
这种方法为研究免疫疗法机制提供了一个独特的窗口.
这些发现支持完善结果预测和开发新的ICB组合.

关键词:

这是一种抗PD-1药物.这是一种抗PD-L1的药物.生物标志物生物标志物癌症免疫疗法免疫疗法临床试验临床试验临床试验临床试验临床试验免疫检查点封锁封锁多种主题的多种主题.这是一种新辅助剂.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...